Merrimack's Mulroy on Success of Pancreatic Drug Onivyde(Audio)
Bloomberg Intelligence10 Maj 2016

Merrimack's Mulroy on Success of Pancreatic Drug Onivyde(Audio)

(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Bob Mulroy, CEO of Merrimack Pharmaceuticals, on biotech earnings, consumer health and oncology, and its product pipeline. Broadcasting live from the Boston Convention and Exhibition Center.

See omnystudio.com/listener for privacy information.

Populärt inom Business & ekonomi

framgangspodden
varvet
badfluence
rss-borsens-finest
uppgang-och-fall
svd-ledarredaktionen
avanzapodden
lastbilspodden
rikatillsammans-om-privatekonomi-rikedom-i-livet
rss-kort-lang-analyspodden-fran-di
fill-or-kill
rss-dagen-med-di
affarsvarlden
kapitalet-en-podd-om-ekonomi
dynastin
borsmorgon
tabberaset
montrosepodden
rss-inga-dumma-fragor-om-pengar
borslunch-2